the market doesn't agree with you. Small trial, only 6 out of 11...

First 617 Last

Share
Profile

Follow
Milcom

1,296 Posts.

383

20/02/24

12:36

Post #: 72498266
Share

Originally posted by dalts66: ↑

I dont agree.

CHM have efficacy against a solid tumour cancer using CarT. That's huge.

They have shown safety and disease control against GBM. Also huge. To have a treatment work across the blood brain barrier and be safe an effective is an incredible accomplishment.

One of the approved FDA drugs for GBM received approval with only 20% response rate. And its mean survival rate is significantly less than what CHM achieved. So even a reduction in response rate over a larger cohort size, as long as safety remains the same, will still see a fast track approval pathway.

So small cohort number or not, the results are indeed impressive.

Lets see what the expansion trial can achieve.

And then of course there is the rest of the pipeline which is also already hitting arms or about to hit arms.

Last time I checked CHM wasn't a charity. So I dont understand why you should expect someone to take a pay cut to come and work for them. Without the right people these drugs wont progress. And the pipeline progressing efficiently and effectively is what determines if a drug discovery biotech succeeds or not.

Expand

the market doesn't agree with you. Small trial, only 6 out of 11 showed disease control. Only 2 out of the 11 showed any promise. That's not good. Hence 2.5c

She took a paycut? Where exactly do you think she was before becoming CEO/MD of CHM?

CHM Price at posting: 2.5¢ Sentiment: Sell Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: Futures rocket on 'total and complete' Israel-Iran ceasefire | June 24

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

SFX

Sheffield Resources spruiks 'pleasing' maiden MRE at South Atlantic Project

Markets were expecting Trump to bomb Iran. It's just another new normal

ASX Market Close: Middle East War rattles investors | June 23, 2025

First 617 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.4¢		Change 0.000(0.00%)		Mkt cap ! $8.060M

Open	High	Low	Value	Volume
0.4¢	0.5¢	0.4¢	$11.72K	2.783M

Buyers (Bids)

No.	Vol.	Price($)
4	2757364	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	15260220	25

View Market Depth

No.	Vol.	Price($)
2	1754304	0.005
5	2882364	0.004
42	27878271	0.003
15	13950505	0.002
10	50600000	0.001

Price($)	Vol.	No.
0.004	1754305	1
0.005	13492653	21
0.006	13217229	15
0.007	3200000	3
0.008	8542434	6

Last trade - 16.10pm 23/06/2025 (20 minute delay)

CHM (ASX) Chart

the market doesn't agree with you. Small trial, only 6 out of 11...

Top Stories

ASX Market Open: Futures rocket on 'total and complete' Israel-Iran ceasefire | June 24

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Sheffield Resources spruiks 'pleasing' maiden MRE at South Atlantic Project

Markets were expecting Trump to bomb Iran. It's just another new normal

ASX Market Close: Middle East War rattles investors | June 23, 2025

Buyers (Bids)

Sellers (Offers)